C57BL/6N-Zbtb24tm1.1Ics/Ics

Status

Available to order

EMMA IDEM:16204
Citation informationRRID:IMSR_EM:16204 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6N-Zbtb24tm1.1Ics/Ics
Alternative nameZbtb24tm1.1Ics/Ics
Strain typeTargeted Mutant Strains : Point mutation
Allele/Transgene symbolZbtb24tm1.1Ics
Gene/Transgene symbolZbtb24

Information from provider

ProviderClaire Francastel
Provider affiliationBâtiment Lamarck B, UMR 7216 – Épigénétique et Destin Cellulaire
Genetic informationTwo nucleotides (TA) were deleted from histidine codon 132 and serine codon 133 (CAtaGC) (c.396_397del) in exon 2, leading to a frameshift and premature stop codon (p.H132Qfs*21). A loxP site-flanked neo resistance gene and protamine promotor-driven cre gene cassette were inserted into and auto-excised from intron 2. The mutation is the equivalent of a human mutation associated with ICF2 syndrome (Immunodeficiency with Centromeric instability and Facial anomalies 2; OMIM #614069).
Phenotypic informationHomozygous:
N/A

Heterozygous:
N/A
Breeding historyC57BL/6NCrl 75%, C57BL/6NTac 25%
References
  • ZBTB24 is a conserved multifaceted transcription factor at genes and centromeres that governs the DNA methylation state and expression of satellite repeats.;Grillo Giacomo, Boyarchuk Ekaterina, Mihic Seed, Ivkovic Ivana, Bertrand Mathilde, Jouneau Alice, Dahlet Thomas, Dumas Michael, Weber Michael, Velasco Guillaume, Francastel Claire, ;2025;Human molecular genetics;34;161-177; 39562305
Homozygous fertilenot known
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • abnormal retina blood vessel morphology / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • abnormal lens morphology / IMPC
  • increased circulating HDL cholesterol level / IMPC
  • decreased red blood cell distribution width / IMPC
  • increased startle reflex / IMPC
  • decreased circulating chloride level / IMPC
  • abnormal retina vasculature morphology / IMPC
MGI phenotypes (gene matching)
  • embryonic lethality between implantation and placentation, complete penetrance / MGI

Literature references

  • ZBTB24 is a conserved multifaceted transcription factor at genes and centromeres that governs the DNA methylation state and expression of satellite repeats.;Grillo Giacomo, Boyarchuk Ekaterina, Mihic Seed, Ivkovic Ivana, Bertrand Mathilde, Jouneau Alice, Dahlet Thomas, Dumas Michael, Weber Michael, Velasco Guillaume, Francastel Claire, ;2025;Human molecular genetics;34;161-177; 39562305

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).